Search results for "table"

showing 10 items of 2807 documents

Fruit and Vegetable Intake and Non-Communicable Diseases among Adults Aged ≥50 Years in Low- and Middle-Income Countries.

2022

Abstract Objectives The relationship between consuming ≥2 servings of fruits and ≥3 servings of vegetables a day, which has been identified as optimal for health (i.e., adequate fruit/vegetable consumption), and non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) is largely unknown. Therefore, using data from six LMICs, we investigated the independent association between inadequate fruit/vegetable consumption and 12 NCDs, and estimated the prevalence of inadequate fruit/vegetable consumption among people with NCDs. Design and Setting Cross-sectional, nationally representative data from the WHO Study on global AGEing and adult health (SAGE) were analyzed. Participant…

MaleLung DiseasesNutrition and DieteticsVision DisordersMedicine (miscellaneous)DietCross-Sectional StudiesFruitVegetablesHumansFemaleGeriatrics and GerontologyNoncommunicable DiseasesDeveloping CountriesFruit and vegetable adults epidemiology low- and middle-income countries non-communicable diseaseThe journal of nutrition, healthaging
researchProduct

An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group.

2009

Maternal dietary data from an international collaborative case-control study on childhood brain tumors were used to evaluate associations between histology-specific risk and consumption of specific food groups during pregnancy.Nine study centers from seven countries contributed 1218 cases and 2223 controls. Most cases were diagnosed between 1982 and 1992 and ranged in age from 0 to 19 years. Dietary consumption was measured as average grams per day.Foods generally associated with increased risk were cured meats, eggs/dairy, and oil products; foods generally associated with decreased risk were yellow-orange vegetables, fresh fish, and grains. The cured meat association was specific to astroc…

MaleMESH: Meat ProductsEpidemiologyFood group0302 clinical medicineMESH: Nitroso CompoundsMESH: PregnancyPregnancyRisk FactorsMESH: Risk FactorsMESH: ChildVegetables030212 general & internal medicineChild2. Zero hungerBrain NeoplasmsCruciferous vegetablesMESH: Infant NewbornAstrocytomaMESH: Case-Control StudiesMESH: Infant3. Good healthMeat ProductsQuartileMESH: Young AdultChild PreschoolPrenatal Exposure Delayed Effects030220 oncology & carcinogenesisMESH: Brain NeoplasmsFemaleNitroso Compoundsmedicine.medical_specialtyAdolescent[SDV.CAN]Life Sciences [q-bio]/CancerArticleMESH: Prenatal Exposure Delayed EffectsYoung Adult03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerMESH: DietInternal medicinemedicineHumansMESH: AdolescentPregnancyMESH: Humansbusiness.industryMESH: Child PreschoolInfant NewbornCase-control studyInfantOdds ratiomedicine.diseaseMESH: VegetablesMESH: MaleDietSurgery[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCase-Control StudiesAttributable risk[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH: Female
researchProduct

Dietary habits of adolescents living in North America, Europe or Oceania: A review on fruit, vegetable and legume consumption, sodium intake, and adh…

2019

Abstract Aims This review aimed at investigating fruit, vegetable and legume consumption, salt/sodium intake, and the adherence to the Mediterranean dietary pattern in adolescents, three key aspects towards the adoption of a healthy diet. Data synthesis Three separate searches were carried out on PubMed and Scopus, using the same procedure, searching for studies published in the previous decade with data on fruit and/or vegetable or legume consumption, salt or sodium intake, and adherence to the Mediterranean Diet assessed using the KIDMED questionnaire. The review included a total of 58 papers, which describe original investigations on healthy adolescents (10–19 years old) living in North …

MaleMediterranean climateAdolescentMediterranean dietAdolescent Nutritional Physiological PhenomenaEndocrinology Diabetes and MetabolismSaltOceaniaChild BehaviorNutritional StatusMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyBiologyDiet MediterraneanRecommended Dietary AllowancesYoung Adult03 medical and health sciences0302 clinical medicineEnvironmental healthVegetablesAdolescence; Fruit & vegetable; Legume; Mediterranean Diet; SaltHumansChildLegumeConsumption (economics)Nutrition and DieteticsMediterranean DietFruit & vegetableData synthesisAge FactorsBehavioural interventionFabaceaeSodium DietaryFeeding BehaviorHealthy dietAdolescenceLegumeSodium intakeEuropeAdolescent BehaviorFruitNorth AmericaFemaleDiet HealthyCardiology and Cardiovascular MedicineNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Total polyphenol excretion and blood pressure in subjects at high cardiovascular risk.

2011

Background and aims Dietary factors are critical for the prevention and treatment of hypertension, but data on the effects of specific nutrients on blood pressure (BP) are scarce. The aim of this study was to assess the relationship between total polyphenol excretion (TPE) in urine, as an objective measurement of total polyphenol intake and BP in an elderly population at high cardiovascular risk. Methods and results Cross-sectional substudy of 589 high-risk participants entering in the PREDIMED trial. BP was measured and TPE was determined in urine by Folin–Ciocalteu assay. A significant positive association was observed between TPE in urine and daily intake of fruit and vegetables (F&V), c…

MaleMediterranean dietCross-sectional studyEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyBlood PressureWine0939-4753UrineCoffeeRisk FactorsCoffeesSurveys and QuestionnairesVegetablesOdds RatioPrevalenceRandomized Controlled Trials as Topiceducation.field_of_studyBioquímica y tecnologíaNutrition and DieteticsMediterranean Regionfood and beveragesMiddle AgedBlood presureUrinary polyphenolFolin-CiocalteuBiochemistry and technologyPolifenolsHypertensionFemaleHipertensióCardiology and Cardiovascular MedicinePolyphenolmedicine.medical_specialtyPopulationRenal functionPressió sanguíniaBioquímica i biotecnologiaFruitsExcretionPhenolsMediterranean dietmedicineHumanseducationAgedFlavonoidsbusiness.industryPolyphenolsOdds ratioDietSurgeryCross-Sectional StudiesBlood pressureFruitMultivariate AnalysisLinear ModelsbusinessBiomarkers
researchProduct

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

2018

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire…

MaleMediterranean dietCross-sectional studyMetabolic disordersSocial Sciencescardiovascular-diseaselaw.invention613 - Higiene en general. Higiene i salut personalEndocrinology0302 clinical medicinepreventionPsychologyPublic and Occupational HealthMental health and psychiatryadherencelcsh:Sciencemediana edadvalidationancianodieta3. Good healthhealth-statusdepressionObesitatDietaEndocrine Disorders03 medical and health sciencesCuina mediterràniaDiabetes MellitusHumansobesidadAgedPhysical activitylcsh:RassociationBiology and Life Sciencesbenefitsmedicine.diseaseObesitymortalityBenefitsAgronomyHealth CareCross-Sectional Studiesphysical-activity questionnairelcsh:QMetabolic syndromeOlder peopleestudios transversalesGerontologycumplimiento del pacienteEmotionshumanoslcsh:Medicine030204 cardiovascular system & hematologyOverweightDiet MediterraneanDieta mediterràniaPersones gransClinical trialsQuality of lifeRandomized controlled triallawPlant ProductsMedicine and Health Sciences030212 general & internal medicine2. Zero hungerMetabolic SyndromeMultidisciplinarysobrepesotratamiento por actividad físicaAgricultureMiddle AgedPhysical-activity questionnaireHealth-statusExercise TherapyQualitat de vidaHypertensionFemalemedicine.symptomResearch ArticleMediterranean cookingMediterranean dietmedicineObesityMortalityNutritionbusiness.industryOverweightMental healthDietSpaincalidad de vidaQuality of LifePatient ComplianceVegetable oilsbusinessCrop ScienceAssaigs clínics
researchProduct

Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk populat…

2009

Inflammation is involved in cardiovascular diseases. Some studies have found that the Mediterranean diet (MD) can reduce serum concentrations of inflammation markers. However, none of these studies have analyzed the influence of genetic variability in such a response. Our objective was to study the effect of the -765G>C polymorphism in the cyclooxygenase-2 (COX-2) gene and the -174G>C polymorphism in the interleukin-6 (IL-6) gene on serum concentrations of IL-6, C-reactive protein, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule-1 as well as their influence on the response to a nutritional intervention with MD. An intervention study in a high cardiovascular ri…

MaleMediterranean dietVascular cell adhesion molecule-1Suplements nutritiusMedicine (miscellaneous)InterleucinesDiet MediterraneanOlis vegetalsPolymorphism (computer science)Nutseducation.field_of_studyNutrition and DieteticsbiologyBiochemical markersPlant oilsMiddle AgedIntercellular Adhesion Molecule-1Dietary supplementsInflamacióOli d'olivaC-Reactive ProteinCardiovascular diseasesCardiovascular DiseasesMarcadors bioquímicsFemalemedicine.symptommedicine.medical_specialtyDiet therapyPopulationVascular Cell Adhesion Molecule-1InflammationDried fruitGenetic polymorphismsMediterranean cookingInternal medicineCuina mediterràniamedicineHumansPlant OilsGenetic variabilityInterleukin 6educationOlive OilAgedInflammationPolymorphism GeneticInterleukin-6Malalties cardiovascularsPolimorfisme genèticInterleukinsEndocrinologyGene Expression RegulationCyclooxygenase 2Immunologybiology.proteinCyclooxygenaseVegetable oilsFruita secaBiomarkersOlive oil
researchProduct

Minimal clinically important difference and minimal detectable change of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0…

2020

Objectives: The aim of this study is to estimate a minimal clinically important difference (MCID) and a minimal detectable change (MDC) of the 12-item WHODAS 2.0 amongst patients with chronic musculoskeletal pain. Design: Cross-sectional cohort study. Setting: Outpatient Physical and Rehabilitation Medicine clinic. Subjects: A total of 1988 consecutive patients with musculoskeletal pain. Interventions: A distribution-based approach was employed to estimate a minimal clinically important difference, a minimal detectable change, and a minimal detectable percent change (MDC%). Results: The mean age of the patients was 48 years, and 65% were women. The average intensity of pain was 6,3 (2.0) po…

MaleMusculoskeletal painSchedule2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)WHODASPhysical Therapy Sports Therapy and Rehabilitationminimal detectable changetuki- ja liikuntaelimetWorld healthDisability assessmentCohort StudiesDisability EvaluationMusculoskeletal PainHumansMedicineskin and connective tissue diseasesmusculoskeletal painPain Measurementbusiness.industryMinimal clinically important differenceminimal clinically important differenceRehabilitationkipuMiddle AgedCross-Sectional StudiesPhysical therapyFemalesense organsWhodasChronic PainbusinessData Collection toolsClinical Rehabilitation
researchProduct

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-l…

2009

Udgivelsesdato: 2009-Jun-20 BACKGROUND: Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people with type 2 diabetes. We assessed cardiovascular outcomes after addition of rosiglitazone to either metformin or sulfonylurea compared with the combination of the two over 5-7 years of follow-up. We also assessed comparative safety. METHODS: In a multicentre, open-label trial, 4447 patients with type 2 diabetes on metformin or sulfonylurea monotherapy with mean haemoglobin A(1c) (HbA(1c)) of 7.9% were randomly assigned to addition of rosiglitazone (n=2220) or to a combination of metformin and sulfonylurea (active con…

MaleMyocardial InfarctionAdministration OralType 2 diabeteslaw.inventionFractures BoneRandomized controlled triallawNeoplasmsClinical endpointMyocardial infarctionrosiglitazone; cardiovascular outcomesProspective StudiesDiureticsGeneral MedicineMiddle AgedMetforminMetforminHospitalizationStrokeDrug Therapy CombinationFemaleRosiglitazonemedicine.drugmedicine.medical_specialtyRosiglitazoneSex FactorsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsAngina UnstableDiabetes Rosiglitazone Cardiovascular RiskHemoglobin A GlycosylatedGlycated HemoglobinHeart FailureIntention-to-treat analysisbusiness.industryBody WeightCholesterol HDLCholesterol LDLtype 2 diabetes; rosiglitazonemedicine.diseaseDrug UtilizationSurgerySulfonylurea CompoundsDiabetes Mellitus Type 2ThiazolidinedionesHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessLancet (London, England)
researchProduct

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

2015

BACKGROUND: Cardiovascular morbidity and mortality are higher among patients with type 2 diabetes, particularly those with concomitant cardiovascular diseases, than in most other populations. We assessed the effects of lixisenatide, a glucagon-like peptide 1-receptor agonist, on cardiovascular outcomes in patients with type 2 diabetes who had had a recent acute coronary event.METHODS: We randomly assigned patients with type 2 diabetes who had had a myocardial infarction or who had been hospitalized for unstable angina within the previous 180 days to receive lixisenatide or placebo in addition to locally determined standards of care. The trial was designed with adequate statistical power to …

MaleMyocardial InfarctionKaplan-Meier Estimate2700 General MedicineType 2 diabetesAnginachemistry.chemical_compoundTreatment FailureMyocardial infarctionResearch Support Non-U.S. Gov'tHemoglobin AGeneral MedicineAnginaMiddle AgedMulticenter StudyCardiovascular DiseasesRandomized Controlled TrialCardiologyFemalelixisenatideType 2medicine.medical_specialtyAcute coronary syndromeGlycosylated610 Medicine & healthUnstableGlucagon-Like Peptide-1 Receptor11171 Cardiocentro TicinoLixisenatideAcute Coronary Syndrome; Aged; Angina Unstable; Cardiovascular Diseases; Diabetes Mellitus Type 2; Female; Glucagon-Like Peptide-1 Receptor; Hemoglobin A Glycosylated; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peptides; Proportional Hazards Models; Treatment FailureInternal medicineJournal ArticleDiabetes MellitusmedicineHumansHypoglycemic AgentsAngina UnstableAcute Coronary SyndromeAgedProportional Hazards ModelsHemoglobin A GlycosylatedUnstable anginabusiness.industrySemaglutideta3121medicine.diseaseDiabetes Mellitus Type 2chemistryMyocardial infarction complicationsPeptidesbusinessNew England Journal of Medicine
researchProduct

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2020

Background Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the…

MaleNutritional SciencesSpecific riskContaminación del Aire Interior030204 cardiovascular system & hematologySocioeconomic Factorsystematic analysisGlobal HealthBody Mass IndexGlobal Burden of DiseaseHealth Risk BehaviorHealth Risk BehaviorsDisease studies0302 clinical medicineRisk FactorsMETABOLIC RISKS030212 general & internal medicine11 Medical and Health SciencesFactores de Riesgo2. Zero hungereducation.field_of_studyPublic healthInjuriesPublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineGBD; risck factors; attributable burden of disease;3142 Public health care science environmental and occupational health3. Good healthRelative riskEnvironmental healthHealthHypertension/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingGlobal Burden of Diseases Injuries Risk FactorsA990 Medicine and Dentistry not elsewhere classifiedFemaleLeading risk factorsGlobal Health MetricsCohort studyHumanmedicine.medical_specialtySubstance-Related DisordersPopulationUNITED-STATESRisk AssessmentDIETITC-HYBRID03 medical and health sciencesLife ExpectancyUNITED-STATES; MORTALITY; DISABILITY; POLLUTION; CLUSTERS; DIETSDG 3 - Good Health and Well-beingPOLLUTIONGeneral & Internal MedicineEnvironmental healthmedicineHumansGlobal Burden of Disease StudyRisk factoreducationGlobal burdenbusiness.industryPublic healthRisk FactorMORTALITYDISABILITYMalnutritionKlinisk medicinGlobal Burden of DiseasesEnvironmental Exposuremedicine.diseaseEnfermedades//purl.org/pe-repo/ocde/ford#3.02.00 [https]MalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologiYears of potential life lostSocioeconomic FactorsRisk factorsDisease studyRelative riskHyperglycemiaITC-ISI-JOURNAL-ARTICLENAClinical MedicinebusinessCLUSTERSRA
researchProduct